Showing results (1-10 of 302) with videos related to
Sort By:
Pageof 31
APMIS. Supplementum|May 13, 2003
Immune selection in murine tumors. Ph.d thesisInge Marie Svane, Anne-Marie EngelMethods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Analysis of survivin-specific T cells in breast cancer patients using human DCs engineered with survivin mRNAOzcan Met, Inge Marie SvaneCancer Immunology, Immunotherapy : CII|August 8, 2014
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?Inge Marie Svane, Els M VerdegaalOncoimmunology|May 8, 2015
Indoleamine 2,3-dioxygenase vaccinationMads Hald Andersen, Inge Marie SvaneSeminars in Immunopathology|October 13, 2016
Cancer immunotherapy in patients with preexisting autoimmune disordersMarco Donia, Magnus Pedersen, Inge Marie SvaneMolecular Biotechnology|June 11, 2008
Studies on mRNA electroporation of immature and mature dendritic cells: effects on their immunogenic potentialOzcan Met, Jens Eriksen, Inge Marie SvaneEuropean Journal of Cancer (Oxford, England : 1990)|January 26, 2025
Neoadjuvant or perioperative immunotherapy for resectable melanoma: The need for biomarkersEva Ellebaek, Marco Donia, Inge Marie SvaneCytotherapy|May 7, 2013
Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cellsDominique Cathelin, Özcan Met, Inge Marie SvaneEuropean Urology|May 6, 2006
Therapeutic dendritic cell vaccination of patients with renal cell carcinomaAnnika Berntsen, Poul F Geertsen, Inge Marie SvaneOncoimmunology|May 4, 2016
The controversial role of TNF in melanomaMarco Donia, Julie Westerlin Kjeldsen, Inge Marie SvanePageof 31